samedan logo

home > news > detailed info

Volga-Dnepr Group Strengthens its Global Healthcare Team

Volga-Dnepr Group

Volga-Dnepr Group, the group of international air cargo carriers with 30+ years of profound expertise in transporting various types of cargo, has strengthened its Global Healthcare Team to support its customers worldwide with comprehensive logistics solutions for their pharmaceutical products.

The team will be led by Yulia Celetaria, Healthcare Director who will be in charge of smooth operations of the Group, alignment of dedicated healthcare and life-saving services with the usage of the Group’s unique freighter fleet, network connections through scheduled flights and charter options. While previously working for AirBridgeCargo Airlines, where she started her professional journey back in 2005, Yulia has been able to upscale her knowledge, expertise and gain the right experience necessary to meet the 2020 logistics challenge of the whole pharmaceutical industry.

The team, consisting of regional experts with in-depth market knowledge, will work closely with all the stakeholders, starting from pharmaceutical manufacturers, freight forwarders, road feeder providers up to ground handling agents, last-mile delivery companies and final consignee, as well as global healthcare organizations and local regulators.

With the top priority being the organization of efficient and safe transportation of COVID-19 vaccines, the Group has also set a dedicated Vaccine Task Force, which will be fronted by Casper Pan, Head of Healthcare APAC, who has been part of Volga-Dnepr Group for a long time, possesses the unique knowledge and is well-experienced in pharmaceutical logistics. The complete team follows the global vaccine development trends and implements the necessary changes to the existing processes to provide high-quality services and guarantee vaccine integrity.

Yulia Celetaria, Healthcare Director of the Group highlights: “We have aligned our organizational chart to embrace various levels of operational process – Sales, Procurement, Operations, which enables us to meet the customers’ needs and provide 360-degree coverage of the situation, which sometimes changes at a sky-rocket pace. With our qualified and experienced team members who possess the right combination of hard and soft skills and are devoted to lifelong learning, we are able to meet the logistics challenges of yesterday, today and tomorrow”.

For the first 9 months of 2020, the Group has managed to triple its healthcare and humanitarian volumes surpassing the point of over 55,000 tonnes, delivering essential cargo amid the pandemic and offering dedicated logistics solutions for a wide range of shipments – PPE, medical equipment, temperature-sensitive medical products, sophisticated and delicate vaccines, oversized medical and disinfecting vehicles and others.
phone +7 495 755 6850 / 755 7836
email Mezhdunarodnoye shosse, Skypoint Business Park, 28B Bld., Moscow, 141411, Russia
Print this page
Send to a friend
News and Press Releases

Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 L858R mutations as detected by an approved test.
More info >>

White Papers

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement